Next Article in Journal
Forced Degradation Studies to Identify Critical Process Parameters for the Purification of Infectious Measles Virus
Next Article in Special Issue
Specificity of Morbillivirus Hemagglutinins to Recognize SLAM of Different Species
Previous Article in Journal
A Combination of Real-Time PCR and High-Resolution Melting Analysis to Detect and Identify CpGV Genotypes Involved in Type I Resistance
Previous Article in Special Issue
BST2/Tetherin Overexpression Modulates Morbillivirus Glycoprotein Production to Inhibit Cell–Cell Fusion
Open AccessArticle

Evolution of Attenuation and Risk of Reversal in Peste des Petits Ruminants Vaccine Strain Nigeria 75/1

CIRAD, UMR ASTRE, F-34398 Montpellier, France
ASTRE, Univ Montpellier, CIRAD, INRA, Montpellier, France
Author to whom correspondence should be addressed.
Viruses 2019, 11(8), 724; (registering DOI)
Received: 20 July 2019 / Revised: 3 August 2019 / Accepted: 5 August 2019 / Published: 7 August 2019
(This article belongs to the Special Issue Morbilliviruses)
PDF [2753 KB, uploaded 23 August 2019]
  |     |  


Peste des Petits Ruminants (PPR) is a highly infectious disease caused by a virus of the Morbillivirus genus. The current PPR eradication effort relies mainly on the implementation of massive vaccination campaigns. One of the most widely used PPR vaccines is the Nigeria 75/1 strain obtained after attenuation by 75 serial passages of the wild type isolate in cell cultures. Here we use high throughput deep sequencing of the historical passages that led to the Nigeria 75/1 attenuated strain to understand the evolution of PPRV attenuation and to assess the risk of reversal in different cell types. Comparison of the consensus sequences of the wild type and vaccine strains showed that only 18 fixed mutations separate the two strains. At the earliest attenuation passage at our disposal (passage 47), 12 out of the 18 mutations were already present at a frequency of 100%. Low-frequency variants were identified along the genome in all passages. Sequencing of passages after the vaccine strain showed evidence of genetic drift during cell passages, especially in cells expressing the SLAM receptor targeted by PPRV. However, 15 out of the 18 mutations related to attenuation remained fixed in the population. In vitro experiments suggest that one mutation in the leader region of the PPRV genome affects virus replication. Our results suggest that only a few mutations can have a serious impact on the pathogenicity of PPRV. Risk of reversion to virulence of the attenuated PPRV strain Nigeria 75/1 during serial passages in cell cultures seems low but limiting the number of passages during vaccine production is recommended. View Full-Text
Keywords: PPR; morbillivirus; attenuation; virulence; wild strain; vaccine; deep sequencing PPR; morbillivirus; attenuation; virulence; wild strain; vaccine; deep sequencing

Figure 1

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited (CC BY 4.0).

Supplementary material

Share & Cite This Article

MDPI and ACS Style

Eloiflin, R.-J.; Boyer, M.; Kwiatek, O.; Guendouz, S.; Loire, E.; Servan de Almeida, R.; Libeau, G.; Bataille, A. Evolution of Attenuation and Risk of Reversal in Peste des Petits Ruminants Vaccine Strain Nigeria 75/1. Viruses 2019, 11, 724.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics



[Return to top]
Viruses EISSN 1999-4915 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top